Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762422 · ClinicalTrials.gov registry record · NA
Serial Phlebotomy in Voluntary Blood Donors
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT02762422 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 84 participants.
The verdict
NCT02762422, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
Blood donation has been proposed to be associated with reduced risk of cardiovascular disease, but the effects of phlebotomy on vascular function in human subjects have not been well characterized. A prospective randomized double-blind study was undertaken to determine the effects of iron loss and red blood cell loss induced by serial phlebotomy on vascular endothelial function in the brachial artery.
Interventions
- OTHER Phlebotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02762422
The ClinicalTrials.gov registry entry for NCT02762422 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phlebotomy is the first listed.
NCT02762422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02762422 about?
NCT02762422 is a clinical study titled "Serial Phlebotomy in Voluntary Blood Donors". Blood donation has been proposed to be associated with reduced risk of cardiovascular disease, but the effects of phlebotomy on vascular function in human subjects have not been well characterized. A prospective randomized double-blind study was undertaken to determine the effects of iron loss and r...
What is the current status of trial NCT02762422?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2009-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT02762422?
The interventions under investigation include: Phlebotomy (OTHER).
Who is sponsoring clinical trial NCT02762422?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.